Solid Biosciences Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Solid Biosciences Inc. reported Cash And Cash Equivalents At Carrying Value of $59.90 million for the year ending 2025.

  • Solid Biosciences Inc. showed a decrease of -25.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Solid Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Solid Biosciences Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 680.2%.
  • Historical annual values: Fiscal year 2025: $59.90 million | Fiscal year 2024: $80.24 million | Fiscal year 2023: $74.02 million | Fiscal year 2022: $155.38 million | Fiscal year 2021: $119.14 million | Fiscal year 2020: $154.74 million | Fiscal year 2019: $76.04 million | Fiscal year 2018: $86.37 million | Fiscal year 2017: $52.08 million | Fiscal year 2016: $7.68 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: